Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In a new study published in the British Journal of Sports Medicine, scientists at NDORMS investigated if chronic inflammation was a feature of Achilles tendinopathy and rupture.

Figure: Schematic summarising the cellular and molecular features of chronic inflammation identified from cross-sectional assessments of functionally distinct tendons.

Achilles tendon disorders including tendinopathy and rupture are a common cause of musculoskeletal pain and disability. These injuries require prolonged rehabilitation and have a high frequency of recurrence.

In a study by Stephanie Dakin et al, entitled ImPAcT (Inflammation and Pain in Achilles Tendinopathy), scientists teamed up with the OxSport and John Radcliffe Trauma teams to investigate the cellular and molecular features of inflammation in patient biopsy samples of tendinopathic and ruptured Achilles.

The aim of the study was to investigate if energy storing tendons such as the Achilles shared common cellular and molecular inflammatory mechanisms with those previously identified in disease of positional shoulder tendons.

The study showed that chronic inflammation was a feature of both mid-portion Achilles tendinopathy and rupture. Tissue inflammation signatures differed in ruptured compared to non-ruptured Achilles, likely to be due to acute inflammation and increased vascularisation resulting from recent trauma.

The investigators concluded that whilst Achilles and rotator cuff tendons are functionally distinct, they share common cellular and molecular inflammatory disease mechanisms, including macrophage and stromal fibroblast activation (summarized below). Future research will focus on developing new therapeutic approaches to promote resolution of inflammation in chronic tendinopathy.

Read the full article in the British Journal of Sports Medicine:

BJSM.jpg

Funding Bodies

ucb-logo-blue.png

ArthritisResearch_HZ_RGB_Logo_300dpi.jpg

NIHR NHS_Logo_Funded by Stamp.jpg

Similar stories

The new Botnar strategy is announced

After a year as the Director of the Botnar Institute for Musculoskeletal Sciences, Professor Jonathan Rees announces a new structure and strategy that will further enhance research and treatment of bone, joint and musculoskeletal conditions.

New global health grant to improve outcomes for patients with hip fracture

Hip fracture patients in Low- and Middle-Income Countries (LMIC) in Asia are set to benefit from a new study that aims to bring best practice programmes to improve quality of life for patients and reduce healthcare costs.

NDORMS welcomes great-granddaughter of former Head of Department

Julia Strubell, great-granddaughter of Professor Josep Trueta, visited NDORMS to find out about his time here and to share her own work with staff and students.

Botnar researchers awarded Fellowships

Arani Vivekanantham has been awarded an NIHR Doctoral Fellowship and a Versus Arthritis Clinical Research Fellowship, and Rachel Kuo was awarded an NIHR Doctoral Research Fellowship.

Better diagnosis and treatment of autoimmune diseases moves a step closer

A study published in Nature outlines a way to find the crucial peptides (protein fragments) that drive autoimmunity, as well as the immune cells that respond to them.

New drug offers hope for people with hand osteoarthritis

A new study, published in Science Translational Medicine by researchers at the University of Oxford has identified that Talarozole, a drug that is known to increase retinoic acid, was able to prevent osteoarthritis (OA) in disease models.